About Maiva Pharma Private Limited
Data last updated:
Maiva Pharma Private Limited is a private limited company based in Bangalore, Karnataka, India, a subsidiary of G A Global Pte. Ltd. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 05 February 1993 and has been in existence for over 33 years.
The company is registered with the Registrar of Companies (ROC), Bangalore, under CIN U24231KA1993PTC013976. Its GSTIN is 33AAACG5033G1Z4 (Tamil Nadu). The company holds 2 GST registrations, of which 1 is active.
The company has an authorised share capital of ₹31.03 Cr and a paid-up capital of ₹24.66 Cr. It was formerly known as Carodian Private Limited and Global Pharmatech Private Limited. It is led by directors including Arumugam Bhaskar Krishna (Managing Director) and Janardhan (Whole-Time Director).
Its last annual general meeting (AGM) was held on 31 October 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Bangalore, Karnataka.
As per the financials filed for FY 2025, the company reported a revenue of ₹399.05 Cr, a growth of 38% compared to the previous year. For the same year it recorded a net profit of ₹77.08 Cr (net margin 19.3%) and EBITDA of ₹127.3 Cr (EBITDA margin 31.9%). Revenue has grown at a compounded annual rate (CAGR) of 34% over three years and 49% over five years.
The company has about 751 employees on its provident fund (EPFO) records. Its group structure includes 1 subsidiary.
The company is associated with 1 brand: Maiva Pharma. As per MCA filings, the company has open charges of ₹822 Cr and satisfied charges of ₹24.1 Cr on record. Court records list 50 cases involving the company, including 32 filed by the company and 18 filed against it; 4 cases are pending. The company has 31 deals on record (20 secondary share transfers, 11 funding rounds), with disclosed funding of ₹482.8 Cr; the latest was in June 2024. Its 7 peer companies in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products) are compared by revenue, 4 larger and 3 smaller; the largest is Torque Pharmaceuticals Private Limited with revenue of ₹404.13 Cr. The company has 14 MSME Form 1 returns on record between 2019 and 2023, listing 134 overdue payments to 22 micro and small suppliers.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website maivapharma.com.
Company details
Name history
Maiva Pharma has undergone 4 name changes throughout its history. The current legal name is Maiva Pharma Private Limited.
| Company Name | Status |
|---|---|
| Maiva Pharma Private Limited | Current |
| Carodian Private Limited | Previous |
| Global Pharmatech Private Limited | Previous |
| Mablecure Private Limited | Previous |
| Global Parenterals Private Limited | Previous |
Contact details
Maiva Pharma Private Limited's registered office is in Bangalore, Karnataka. Its website is maivapharma.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Social Media
- Registered AddressNo. 705 2nd Floor Om Shree Mnv Towers, 5th Block Hmt Layout Vidyaranyapura Main Road, Bangalore, Karnataka, India – 560097
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Maiva Pharma Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Brands
Maiva Pharma operates one associated brand: Maiva Pharma. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Formulation development, analytical validation, and injectable supplies are provided. | maivapharma.com |
Business activity
The main business activity of Maiva Pharma is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Maiva Pharma Private Limited, buy the company report.
Financials of Maiva Pharma Private Limited
FY 2025 filings availableMaiva Pharma Private Limited reported revenue of ₹399.05 Cr (up 38% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 49% over five years, including 38% growth in the latest year. EBITDA rose 82% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹127.3 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹77.08 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 31.9% | ||||
| Net Profit Margin | 19.3% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Maiva Pharma Private Limited, buy the company report.
Board of directors of Maiva Pharma Private Limited
Maiva Pharma has 5 current directors and 24 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Nirav Vinod Mehta Also directs: Maiva Lifesciences Private Limited, Fullife Healthcare Private Limited, R.G. Scientific Enterprises Private Limited and 3 more | Director | 30 Apr 2024 | 2 Years 5 Months | Current |
| Janardhan Also directs: Maiva Lifesciences Private Limited | Whole-Time Director | 25 Aug 2021 | 5 Years 2 Months | Current |
| Arumugam Bhaskar Krishna | Managing Director | 27 May 2013 | 13 Years 5 Months | Current |
| Buggana Hariharnath Also directs: Invascent Advisory Services India LLP, Invascent Ilsf Manager LLP, Symbiotec Zenfold Private Limited and 4 more | Director | 13 Sep 2024 | 2 Years 1 Months | Current |
| Vaibhav Bagri | Director | 31 Jul 2024 | 2 Years 2 Months | Current |
Peer comparison
Maiva Pharma Private Limited is compared with the 7 companies closest to it by revenue in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Torque Pharmaceuticals Private Limited | ₹404.13 Cr (FY 2024) | 1.0% | Chandigarh, India | |||
| Steril-Gene Life Sciences Private Limited | ₹404.06 Cr (FY 2025) | 41.0% | Chennai, Tamil Nadu, India | |||
| Zeiss Pharmaceuticals Private Limited | ₹403.65 Cr (FY 2025) | 6.0% | Nalagarh, Himachal Pradesh, India | |||
| Gland Chemicals Pvt Ltd | ₹401.18 Cr (FY 2022) | 33.0% | Hyderabad, Telangana, India | |||
| Maiva Pharma Private Limitedthis company | ₹399.05 Cr (FY 2025) | ₹77.08 Cr | 19.3% | 38.0% | 751 | Bangalore, Karnataka, India |
| Rusan Pharma Limited | ₹392.15 Cr (FY 2025) | 9.0% | Mumbai, Maharashtra, India | |||
| Hetero Biopharma Limited | ₹387.48 Cr (FY 2024) | 13.0% | Hyderabad, Telangana, India | |||
| Zim Laboratories Limited. | ₹384.82 Cr (FY 2025) | 3.0% | Nagpur, Maharashtra, India |
To see the full peer comparison of Maiva Pharma Private Limited, buy the company report.
Auditor
Maiva Pharma Private Limited is audited by MSKA & Associates for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| MSKA & Associates | FY 2023 | 105047W |
Shareholding
The shareholding of Maiva Pharma Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Maiva Pharma Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 30 Jul 2025 | 101144909 | Others | ₹500 Cr | Open | |
| 20 Oct 2020 | 100381787 | Hdfc Bank Limited | ₹198 Cr | Open | |
| 11 Sep 2020 | 100409611 | Hdfc Bank Limited | ₹124 Cr | Open | |
| 20 Oct 2020 | 100381788 | Hdfc Bank Limited | ₹20 Cr | Satisfied | |
| 25 Mar 2002 | 80006956 | Indian Bank | ₹1.6 Cr | Satisfied |
To see the full charge records of Maiva Pharma Private Limited, buy the company report.
Total charge records: 6 View all charges
Deals & funding
Maiva Pharma Private Limited has 31 deals on record (20 secondary share transfers, 11 funding rounds), with disclosed funding of ₹482.8 Cr; the latest was in June 2024.
Deals on record (5 of 31)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Jul 2019 | Secondary share transfer | Undisclosed | Buyer: G A Global Pte Limited Seller: Exodus Technologies Private Limited |
| Jul 2019 | Secondary share transfer | Undisclosed | Buyer: AGP Global Health Care LLP, an individual Seller: Accusoft Technologies Private Limited , an individual |
| Jun 2016 | Secondary share transfer | Undisclosed | Buyer: an individual Seller: Accusoft Technologies Private Limited |
| Jan 2016 | Funding round · Series A | ₹9.02 Cr | Investors: Pharmascience Inc, Mahaganapati Business Advisors LLP , an individual |
| Mar 2015 | Secondary share transfer | Undisclosed | Buyer: an individual Seller: Accusoft Technologies Private Limited |
To see the full deal history of Maiva Pharma Private Limited, buy the company report.
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
Maiva Pharma Private Limited has 50 court cases on record: 32 filed by Maiva Pharma, 18 filed against it. 4 cases are pending and 46 are disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| High courts | 49 | 17 | 4 |
| District courts | 1 | 1 | 0 |
Cases on record (5 of 50)
| Court | Type of case | Party | Status |
|---|---|---|---|
| Bombay High Court | Court case (SS) | Filed by the company against M/S. Klenzaids Aseptic Technologies Pvt. Ltd. and Ors. | Disposed |
| High Court, TAMIL NADU | Interim or miscellaneous application | Filed against the company by an individual | Pending |
| High Court, TAMIL NADU | Interim or miscellaneous application | Filed by the company against Assistant Commissioner of Labour and 1 other | Pending |
| High Court, TAMIL NADU | Writ petition | Filed by the company against Assistant Commissioner of Labour and 1 other | Pending |
| High Court, TAMIL NADU | Writ petition | Filed against the company by Maiva Pharma Employees Union (R.No.560/Drp) Row and Reddy, KK Ram Siddhartha | Disposed |
To see the full case history of Maiva Pharma Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
Maiva Pharma Private Limited has 14 MSME Form 1 returns on record between 2019 and 2023, listing 134 overdue payments to 22 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (5 of 22)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| Omega Scientific Instruments Private Limited | |||
| Peenya Industrial Gases Private Limited | |||
| an individual supplier | |||
| Creations | |||
| Mack Pharmatech Private Limited |
To see the full MSME payment records of Maiva Pharma Private Limited, buy the company report.
Individuals and sole proprietors among the suppliers are not named.
Group structure & subsidiaries
Maiva Pharma has 1 subsidiary company. This group structure data is as of FY 2023. The table lists each entity with its relationship and holding.
| Company Name | CIN | Shares held |
|---|---|---|
| Maiva Lifesciences Private Limited | U24110TN2022PTC154153 |
To see the full group structure of Maiva Pharma Private Limited, buy the company report.
Employees & EPFO
Maiva Pharma Private Limited has a workforce of 751 employees on its EPFO records as of Apr 03, 2024, across 1 active EPFO establishment.
GST
Maiva Pharma has 2 GST registrations: 1 active and 1 cancelled or inactive.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 33AAACG5033G1Z4 | Tamil Nadu | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Maiva Pharma Private Limited, buy the company report.
Recent activity
Maiva Pharma Private Limited has 29 board changes on record since 2007: 6 appointments and 23 cessations. The latest: Buggana Hariharnath ceased to be Additional Director on 05 Nov 2024.
34 earlier events are in the company report.
News
Frequently asked questions
Maiva Pharma is an active private limited company based in Bangalore, Karnataka, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 05 February 1993 (33+ years old) and is registered under CIN U24231KA1993PTC013976.
Maiva Pharma has 5 current directors:
- Arumugam Bhaskar Krishna - Managing Director
- Janardhan - Whole-Time Director
- Nirav Vinod Mehta - Director
- Buggana Hariharnath - Director
- Vaibhav Bagri - Director
The latest financial statements of Maiva Pharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 31 October 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Maiva Pharma is 33AAACG5033G1Z4, registered in Tamil Nadu. The company has 2 GST registrations in all, of which 1 is active and 1 is cancelled or inactive.
The CIN (Corporate Identification Number) of Maiva Pharma is U24231KA1993PTC013976. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Maiva Pharma has 50 court cases on record: 32 filed by the company and 18 filed against it. 4 are pending. Most are in the high courts.
Maiva Pharma was incorporated on 05 February 1993, making it 33+ years old. It is registered with the Registrar of Companies, Bangalore.
Maiva Pharma has 31 deals on record (20 secondary share transfers, 11 funding rounds), with disclosed funding of ₹482.8 Cr; the latest was in June 2024.
The peers of Maiva Pharma by revenue are Torque Pharmaceuticals Private Limited, Steril-Gene Life Sciences Private Limited, Zeiss Pharmaceuticals Private Limited, Gland Chemicals Pvt Ltd, Rusan Pharma Limited and 2 more, all in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Buggana Hariharnath ceased to be Additional Director on 05 Nov 2024. Vaibhav Bagri ceased to be Nominee Director on 05 Nov 2024. Buggana Hariharnath was appointed as Director on 13 Sep 2024. Maiva Pharma has 29 board changes on record in total.
Maiva Pharma has 14 MSME Form 1 returns on record between 2019 and 2023, listing 134 overdue payments to 22 micro and small suppliers. The latest return was filed on 10 Nov 2023.
Maiva Pharma can be reached through the website maivapharma.com. Its registered office is in Bangalore, Karnataka, India.